Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


Discriminatory Vaccine Policy Based on Falsified Paper

WASHINGTON, Nov. 17, 2012 /PRNewswire/ -- CoMeD -- As the Inspector General for Health and Human Services names vaccine researcher Poul Thorsen as one of its "Most Wanted" fugitives, the defense of mercury as 'safe in vaccines' seems to be crumbling.

In 2010, the Coalition for Mercury-free Drugs (CoMeD, Inc.) submitted an allegation to the Inspector General, that studies showing mercury-containing vaccines to be safe, are fraudulent. Now, a new "wanted" posted featuring Danish vaccine researcher Poul Thorsen, issued by the Inspector General  (HHS-OIG), offers proof this allegation is credible.

It is estimated that Poul Thorsen embezzled at least one million dollars of grant money from the CDC, while he co-authored, "Thimerosal and the occurrence of autism …".  CDC documents, obtained through FOIA, also show that Thorsen and his co-authors concealed the fact that autism declined in Denmark after Thimerosal was removed from the Danish vaccine program. 

Today, the US Government and the World Health Organization defend the ongoing use of Thimerosal, the highly toxic mercury-based vaccine preservative, based on a handful of industry-sponsored statistical studies, including Thorsen's. The manufacturer's Material Safety Data Sheet for Thimerosal, however, lists mental retardation as a possible outcome from exposure in utero and in children.  

Based on Thorsen's public conclusion, Dr. Jose Cordero, former US Assistant Surgeon General, declared that "(Thorsen's) Danish study…provide(s) one strong piece of evidence that Thimerosal is not causally linked to autism." Disturbingly, this study also helped the Institute of Medicine reach its 2004 declaration that mercury in vaccines is unrelated to the autism epidemic.

Globally, the proponents for Thimerosal-preserved vaccines are using this questionable research to justify providing mercury-preserved vaccines to developing countries.  While children in developed, western, nations receive mercury-free vaccine formulations, children in developing countries receive many mercury-preserved ones.

At the fourth meeting of the United Nations Intergovernmental Negotiating Committee (INC4) to write a global treaty on mercury, Rev. Lisa K. Sykes, President of CoMeD, Inc., termed this double standard in vaccine safety a form of discrimination based on economics and nationality.  It now seems this discrimination is also based upon falsified data and criminal conduct.

Despite this, the US National Institutes of Health and Centers for Disease Control and Prevention continue to collaborate with Poul Thorsen, using federal funds.  Thorsen remains in Denmark, and no date for his extradition has been made public.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
DevOps Summit, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud ...
I want to start by saying that, at ActiveState, we absolutely love Docker. We think it's phenomenal technology that is really becoming the global currency of the cloud. We've written about Docker a lot on the ActiveState blog – we've celebrated its birthday, discussed evolving technolo...
Containers are revolutionizing the way we deploy and maintain our infrastructures, but monitoring and troubleshooting in a containerized environment can still be painful and impractical. Understanding even basic resource usage is difficult – let alone tracking network connections or ma...
Manufacturing has widely adopted standardized and automated processes to create designs, build them, and maintain them through their life cycle. However, many modern manufacturing systems go beyond mechanized workflows to introduce empowered workers, flexible collaboration, and rapid i...
Leaving aside (most of) the deeper technical details of the situation, an interesting development occurred in the open source community this week. Under the auspices of The Linux Foundation, a new ‘neutral’ coding community emerged as a result of the coming together of the Node.js and...
IBM is delivering of enterprise class containers that make it easier for clients to deliver production applications across their hybrid environments. Containers give developers flexibility to build once and move applications without the need to rewrite or redeploy their code. IBM Con...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE